Yao Wang

Yao Wang has a wealth of experience in the pharmaceutical and biopharmaceutical industries. In 2021, they were a Principal at JHMH Pharma Consulting, a Global Clinical Lead at Oncternal Therapeutics, and an Executive Director at Intra-Cellular Therapies. In 2019, they were a Senior Medical Director at Amgen. From 2017 to 2021, they were a Senior Medical Director at Celgene. From 2015 to 2017, they were a Senior Medical Director at Kyowa Kirin, Inc.- U.S. From 2009 to 2015, they were a Program Physician at Forest Laboratories (now Allergan). In 2007, they were a CRA/Clinical Scientist at Omnicare Clinical Research/Contract to work on Astra Zeneca PLATO study. In 2022, they will become the Chief Medical Officer at Kangpu Biopharmaceuticals, Ltd.

Yao Wang attended the University of Notre Dame, followed by Peking University Health Science Center.